首页> 外文期刊>Retina >Methylprednisolone concentrations in the vitreous and the serum after pulse therapy.
【24h】

Methylprednisolone concentrations in the vitreous and the serum after pulse therapy.

机译:脉冲治疗后玻璃体和血清中甲泼尼龙的浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Intravenous (i.v.) pulse of corticosteroids has been used to treat severe eye inflammation from different origins. Whether such large doses result in vitreous levels that differ either in magnitude or duration from more conventional corticotherapy remain unsolved issues. The authors therefore determined levels of methylprednisolone hemisuccinate and methylprednisolone in the vitreous and serum of patients at different times after a single i.v. perfusion of methylprednisolone hemisuccinate. METHODS: Fifty patients scheduled for a first vitrectomy received an i.v. injection of 500 mg hemisuccinate methylprednisolone at different times before surgery (from 15-24 hours). Patients were divided into two groups: those with (n = 21) and without (n = 29) retinal detachment (RD). Pure vitreous samples were analyzed by high-pressure liquid chromatography. RESULTS: Both the ester and the nonester methylprednisolone forms were sampled in the vitreous, showing a slower rate of hydrolysis compared to the serum. On average, the highest concentration of total methylprednisolone in the vitreous was found at 2.5 hours and rapidly decreased for the group of patients with RD. In the group of patients without RD, the highest concentration was reached at 6 hours and then slowly decreased. The antiinflammatory potency in the nondetached retina eyes was approximately 500 times more than in the physiologic vitreous, but despite the route of administration (i.v. or oral), only 1/10 of the corticosteroid serum concentration was measured in the vitreous. CONCLUSION: High concentration of methylprednisolone is achieved by i.v. pulse therapy without changing the kinetic of entry in the vitreous of nondetached retina eyes when compared to conventional oral corticotherapy. Hydrolysis occurs in the vitreous resulting in high rate of active form. Pulse therapy could be considered in cases of severe ocular inflammation involving the posterior segment of the eye.
机译:目的:使用皮质类固醇静脉(i.v.)脉冲治疗来自不同来源的严重眼部炎症。如此大的剂量是否导致玻璃体水平与传统的皮质疗法在大小或持续时间上存在差异,仍未解决。因此,作者在一次静脉输注后的不同时间测定了患者玻璃体和血清中甲基强的松龙半琥珀酸酯和甲基强的松龙的水平。灌注泼尼松龙半琥珀酸酯。方法:预定进行第一次玻璃体切除术的五十名患者接受了静脉注射。在手术前的不同时间(15-24小时)注射500毫克半琥珀酸甲基泼尼松龙。将患者分为两组:具有(n = 21)和没有(n = 29)视网膜脱离(RD)的患者。通过高压液相色谱分析纯玻璃体样品。结果:酯和非酯甲基泼尼松龙均在玻璃体内取样,与血清相比,水解速度较慢。平均而言,玻璃体中总甲基泼尼松龙的最高浓度在2.5小时时发现,对于RD患者组迅速降低。在没有RD的患者组中,在6小时时达到最高浓度,然后缓慢降低。在未分离的视网膜眼中,抗炎药的强度约为生理性玻璃体的500倍,但是尽管有给药途径(静脉或口服),玻璃体中皮质类固醇的血清浓度仅为1/10。结论:静脉内注射可实现高浓度的甲基强的松龙。与传统的口服皮质疗法相比,脉冲疗法不会改变未分离的视网膜眼睛玻璃体的进入动力学。玻璃体中发生水解,导致高活性形式。在涉及眼后段的严重眼部炎症的情况下,可以考虑使用脉冲疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号